Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Medicina (Kaunas) ; 59(4)2023 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-37109657

RESUMEN

BACKGROUND: Previous studies on saccharin and cyclamate were either limited to experimental animals or lacked evaluation of their long-term consumption effects in humans. OBJECTIVES: This study evaluated the effect of chronic consumption of saccharin and cyclamate on biochemical parameters in healthy individuals and patients with type 2 diabetes mellitus. MATERIAL AND METHODS: Healthy and diabetic individuals were classified into two groups based on whether they consumed sweeteners or not. The participants were classified according to the amount of sweetener consumed per day and duration of consumption. Serum catalase activity, peroxynitrite, ceruloplasmin, and malondialdehyde concentrations were determined. Glycated hemoglobin, fasting glucose, creatinine, alanine transaminase, and lipid profile were also evaluated. The results suggest that saccharin and cyclamate increased HbA1C (+11.16%), MDA (+52.38%), TG (+16.74%), LDL (+13.39%), and TC/HDL (+13.11%) in healthy volunteers. Diabetic patients consuming sweeteners showed increased FSG (+17.51%), ceruloplasmin (+13.17%), and MDA (+8.92%). Diabetic patients showed a positive correlation between the number of tablets consumed per day with FSG and serum creatinine. A positive correlation was found between the duration of sweetener consumption and FSG as well as TG. CONCLUSION: Consumption of saccharin and cyclamate affected biochemical parameters related to metabolic functions in a time and dose-dependent manner and appear to increase oxidative stress in healthy and diabetic type 2 patients.


Asunto(s)
Diabetes Mellitus Tipo 2 , Sacarina , Animales , Humanos , Ciclamatos , Ceruloplasmina , Edulcorantes
2.
Sci Rep ; 12(1): 1778, 2022 02 02.
Artículo en Inglés | MEDLINE | ID: mdl-35110608

RESUMEN

Serum total 25-OHD is a main marker of vitamin D which represents the intake and sunlight exposure. Free form of 25-OHD, the small fraction not bound to a transporter protein has been incorporated as a new marker. This cross-sectional study aimed to evaluate the impact of several factors on total and free vitamin D levels in healthy subjects and to find out if the free form of vitamin D could be a better representative of the body's vitamin D status. Total and free 25-OHD were analyzed by ELISA method in a blood sample collected from 391 apparently healthy volunteers (219 female and 172 Male) from Duhok Governorate/Iraq population. Total and free 25-OHD levels were increased proportionally to BMI with lower values seen in the underweight group, also a significant gender differences in total D3 level with higher values in males (23.90 ± 16.41) ng/ml than females (21.24 ± 15.65) ng/ml was observed. Total and Free 25-OHD levels were significantly associated with ages, their deficiency most frequent occurs in the younger ages between (16-25) years old. Smokers had higher level of Total 25-OHD (26.95 ± 19.01) ng/ml and Free 25-OHD (9.47 ± 4.94) pg/ml than nonsmokers (22.14 ± 14.59) ng/ml and (7.87 ± 4.32) pg/ml respectively. A significant increase in Free 25-OHD level in the veiled women (9.12 ± 4.64) ng/ml than unveiled (6.16 ± 3.73) ng/ml with a significant positive correlation between Free 25-OHD level and dress style was also seen. 30% and 33% of the participants whom their daily exposure to sunlight for 30 min and > 1 h respectively were severe deficient in total 25-OHD. 95% of the participants who had Abnormally low level of free D were exposed for ≥ 30 min to sunlight. Daily exposure to sunlight was negatively associated with Free 25-OHD level.


Asunto(s)
Biomarcadores/sangre , Deficiencia de Vitamina D/diagnóstico , Vitamina D/sangre , Vitaminas/sangre , Adolescente , Adulto , Anciano , Estudios Transversales , Femenino , Humanos , Irak/epidemiología , Masculino , Persona de Mediana Edad , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/epidemiología , Adulto Joven
3.
Horm Mol Biol Clin Investig ; 41(3)2020 May 07.
Artículo en Inglés | MEDLINE | ID: mdl-32989959

RESUMEN

Background Irisin, a newly discovered hormone, is secreted into the circulation from skeletal muscles in response to physical exercise. The biochemical parameters related to irisin secretion have not been sufficiently investigated yet. The aim of this study was to examine the effectiveness of exercise on the level of irisin and its correlation with biochemical and oxidative stress parameters. Materials and methods In this pre- and post-test observational study, 39 healthy male volunteers from a military training setting were followed up on between September and November 2015. The individuals who were included in this study were between 22 and 27 years old with an average age of 24. Those with inflammatory disorders or chronic diseases such as diabetes mellitus were excluded from the study. The parameters were measured at the baseline, at 4 weeks, and at 8 weeks of intervention. Results The study found that the systolic and diastolic blood pressures substantially decreased after 8 weeks of intervention. The cholesterol-to-HDL ratio and glucose levels were significantly higher at the baseline compared to 8 weeks. Total protein and albumin were significantly higher following 4 weeks (0.25 and 0.21 g/dL) and 8 weeks (0.32 and 0.16 g/dL), respectively. Meanwhile, total globulin and irisin increased following 8 weeks of the intervention by only 0.16 g/dL and 0.41 µg/mL, respectively. The high sensitivity C-reactive protein (hs-CRP) decreased following 8 weeks (-0.81 µg/mL). The protein carbonyl (PC) decreased following 4 weeks by only 0.34 nmol/L. Conclusions This study demonstrated that military training enhanced irisin hormone secretion following 8 weeks of military exercise.


Asunto(s)
Fibronectinas/sangre , Estrés Oxidativo , Acondicionamiento Físico Humano/métodos , Adulto , Presión Sanguínea , Voluntarios Sanos , Humanos , Masculino , Personal Militar
4.
Medicina (Kaunas) ; 55(10)2019 Oct 09.
Artículo en Inglés | MEDLINE | ID: mdl-31601053

RESUMEN

Background and objectives: This study evaluated the effect of chronic consumption of saccharin on important physiological and biochemical parameters in rats. Materials and Methods: Male Wistar rats were used in this study and were divided into four groups: A control group and three experimental groups (groups 1, 2, and 3) were treated with different doses of saccharin at 2.5, 5, and 10 mg/kg, respectively. Each experimental group received sodium saccharin once per day for 120 days while the control group was treated with distilled water only. In addition to the evaluation of body weight, blood samples [total protein, albumin, glucose, lipid profile, alanine transaminase (ALT), aspartate transaminase (AST), lactate dehydrogenase (LDH), creatinine, and uric acid] and urine (isoprostane) were collected in zero time, and after 60 and 120 days for biochemical evaluation. Liver (catalase activity) and brain (8-hydroxy-2'-deoxyguanosine, 8-OHdG) tissues were collected at time zero and after 120 days. Results: The data showed that saccharin at 5 mg/kg increased body weight of treated rats after 60 (59%) and 120 (67%) days of treatment. Increased concentration of serum glucose was observed after treatment with saccharin at 5 (75% and 62%) and 10 mg/kg (43% and 40%) following 60 and 120 days, respectively. The concentration of albumin decreased after treatment with saccharin at 2.5 (34% and 36%), 5 (39% and 34%), and 10 mg/kg (15% and 21%) after 60 and 120 days of treatment, respectively. The activity of LDH and uric acid increased proportionally with dosage levels and consumption period. There was an increased concentration of creatinine after treatment with saccharin at 2.5 (125% and 68%), 5 (114% and 45%), and 10 mg/kg (26% and 31%) following 60 and 120 days, respectively. Catalase activity and 8-OHdG increased by 51% and 49%, respectively, following 120 days of treatment with saccharin at 2.5 mg/kg. Elevation in the concentration of isoprostane was observed after treatment with saccharin at all doses. Conclusions: The administration of saccharin throughout the treatment period was correlated with impaired kidney and liver function. Both hyperglycemic and obesity-inducing side effects were observed. There was an increased oxidative status of the liver, as well as exposure to increased oxidative stress demonstrated through the increased levels of isoprostane, uric acid, 8-OHdG, and activity of catalase. Therefore, it is suggested that saccharin is unsafe to be included in the diet.


Asunto(s)
Diabetes Mellitus/fisiopatología , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Obesidad/fisiopatología , Sacarina/efectos adversos , Análisis de Varianza , Animales , Diabetes Mellitus/sangre , Diabetes Mellitus/etiología , Modelos Animales de Enfermedad , Riñón/fisiopatología , Hígado/fisiopatología , Masculino , Obesidad/sangre , Obesidad/etiología , Estrés Oxidativo , Ratas , Ratas Wistar , Medición de Riesgo/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...